BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang H, Lee F, Huo T. Major adverse events, pretransplant assessment and outcome prediction. Journal of Gastroenterology and Hepatology 2009;24:1716-24. [DOI: 10.1111/j.1440-1746.2009.06025.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Hsu C, Lee Y, Huang Y, Hsia C, Su C, Lin H, Lee R, Chiou Y, Lee F, Huo T, Lee S. Ascites in patients with hepatocellular carcinoma: prevalence, associated factors, prognostic impact, and staging strategy. Hepatol Int 2013;7:188-98. [DOI: 10.1007/s12072-011-9338-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
2 Sadik KW, Laibstain S, Northup PG, Kashmer D, Schmitt TM, Bonatti HJ. Closure of ascites leaks with fibrin glue injection in patients with end-stage liver disease. J Laparoendosc Adv Surg Tech A 2011;21:609-14. [PMID: 21612447 DOI: 10.1089/lap.2010.0476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
3 Ma T, Li QS, Wang Y, Wang B, Wu Z, Lv Y, Wu RQ. Value of pretransplant albumin-bilirubin score in predicting outcomes after liver transplantation. World J Gastroenterol 2019; 25(15): 1879-1889 [PMID: 31057301 DOI: 10.3748/wjg.v25.i15.1879] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
4 Hsu CY, Lee YH, Hsia CY, Huang YH, Su CW, Lin HC, Lee RC, Chiou YY, Lee FY, Huo TI. Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system. Hepatology. 2013;57:112-119. [PMID: 22806819 DOI: 10.1002/hep.25950] [Cited by in Crossref: 109] [Cited by in F6Publishing: 105] [Article Influence: 12.1] [Reference Citation Analysis]
5 Wiest I, Barreiros AP, Schlitt HJ, Ebert MP, Teufel A Prof. Dr. Dr. Evaluation und Notwendigkeit einer Anpassung des MELD Scores in der Eurotransplantregion. Z Gastroenterol 2021;59:991-4. [PMID: 34507377 DOI: 10.1055/a-1484-1544] [Reference Citation Analysis]